- Home
- SID vs IRON Comparison
SID vs IRON Comparison
Compare SID & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SID
- IRON
- Stock Information
- Founded
- SID 1941
- IRON 2017
- Country
- SID Brazil
- IRON United States
- Employees
- SID N/A
- IRON N/A
- Industry
- SID Steel/Iron Ore
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- SID Industrials
- IRON Health Care
- Exchange
- SID Nasdaq
- IRON Nasdaq
- Market Cap
- SID 2.1B
- IRON 2.1B
- IPO Year
- SID 1997
- IRON N/A
- Fundamental
- Price
- SID $1.61
- IRON $70.28
- Analyst Decision
- SID Strong Sell
- IRON Strong Buy
- Analyst Count
- SID 1
- IRON 10
- Target Price
- SID $1.30
- IRON $97.80
- AVG Volume (30 Days)
- SID 2.2M
- IRON 347.5K
- Earning Date
- SID 11-11-2025
- IRON 11-11-2025
- Dividend Yield
- SID 5.12%
- IRON N/A
- EPS Growth
- SID N/A
- IRON N/A
- EPS
- SID N/A
- IRON N/A
- Revenue
- SID $8,202,474,486.00
- IRON N/A
- Revenue This Year
- SID $4.12
- IRON N/A
- Revenue Next Year
- SID $0.67
- IRON N/A
- P/E Ratio
- SID N/A
- IRON N/A
- Revenue Growth
- SID 2.22
- IRON N/A
- 52 Week Low
- SID $1.24
- IRON $30.82
- 52 Week High
- SID $2.25
- IRON $72.68
- Technical
- Relative Strength Index (RSI)
- SID 62.11
- IRON 67.33
- Support Level
- SID $1.49
- IRON $67.31
- Resistance Level
- SID $1.67
- IRON $69.87
- Average True Range (ATR)
- SID 0.05
- IRON 2.40
- MACD
- SID 0.01
- IRON 0.47
- Stochastic Oscillator
- SID 69.29
- IRON 83.99
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.